CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- 10-KT Report 10-KT
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- NT 10-Q Other NT 10-Q
- 25-NSE Other Notification of Removal from Listing
- DEFA14A Proxy Proxy Materials
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- PRER14A Other PRER14A
- NT 10-Q Other NT 10-Q
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- PRER14A Other PRER14A
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
Page 1 of 1 · 20 filings